Trials / Completed
CompletedNCT00189761
A Study to Assess Efficacy, Safety and Pharmacokinetics of a Tacrolimus New Oral Formulation (MR4) in BMT Recipients
A Phase 2, Open-Label, Multi-Center Study to Assess Efficacy, Safety and Pharmacokinetics of a Tacrolimus New Oral Formulation (MR4) in De Novo Bone Marrow Transplant Recipients
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 20 Years – 54 Years
- Healthy volunteers
- Not accepted
Summary
A study to assess efficacy, safety and pharmacokinetics of a tacrolimus new oral formulation (MR4) in de novo bone marrow transplant recipients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tacrolimus |
Timeline
- First posted
- 2005-09-19
- Last updated
- 2006-09-20
Locations
4 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00189761. Inclusion in this directory is not an endorsement.